Business Description
SLS BIO Co Ltd
ISIN : KR7246250005
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.45 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 1.96 | |||||
Interest Coverage | 7.36 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 7.13 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.1 | |||||
3-Year EBITDA Growth Rate | 61.7 | |||||
3-Year Book Growth Rate | 50.3 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.19 | |||||
9-Day RSI | 41.94 | |||||
14-Day RSI | 41.31 | |||||
6-1 Month Momentum % | 17.72 | |||||
12-1 Month Momentum % | -39.3 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.77 | |||||
Quick Ratio | 6.62 | |||||
Cash Ratio | 5.39 | |||||
Days Inventory | 32.54 | |||||
Days Sales Outstanding | 202.21 | |||||
Days Payable | 46.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.05 | |||||
Forward Dividend Yield % | 1.05 | |||||
5-Year Yield-on-Cost % | 1.05 | |||||
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | 0.95 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.53 | |||||
Operating Margin % | 7.68 | |||||
Net Margin % | 9.64 | |||||
FCF Margin % | 27.79 | |||||
ROE % | 4.99 | |||||
ROA % | 3.32 | |||||
ROIC % | 4.85 | |||||
ROC (Joel Greenblatt) % | 7.92 | |||||
ROCE % | 3.9 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 79 | |||||
PE Ratio without NRI | 79 | |||||
Price-to-Owner-Earnings | 12.45 | |||||
PS Ratio | 7.52 | |||||
PB Ratio | 2.7 | |||||
Price-to-Tangible-Book | 2.75 | |||||
Price-to-Free-Cash-Flow | 26.79 | |||||
Price-to-Operating-Cash-Flow | 15.14 | |||||
EV-to-EBIT | 64.11 | |||||
EV-to-EBITDA | 27.1 | |||||
EV-to-Revenue | 6.32 | |||||
EV-to-FCF | 23.17 | |||||
Price-to-Projected-FCF | 2.91 | |||||
Price-to-Graham-Number | 1.55 | |||||
Price-to-Net-Current-Asset-Value | 4.93 | |||||
Price-to-Net-Cash | 7.3 | |||||
Earnings Yield (Greenblatt) % | 1.56 | |||||
FCF Yield % | 3.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
SLS BIO Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 4,606.621 | ||
EPS (TTM) (â‚©) | 60 | ||
Beta | 0.9 | ||
Volatility % | 59.17 | ||
14-Day RSI | 41.31 | ||
14-Day ATR (â‚©) | 131.168733 | ||
20-Day SMA (â‚©) | 4788.75 | ||
12-1 Month Momentum % | -39.3 | ||
52-Week Range (â‚©) | 3955 - 11320 | ||
Shares Outstanding (Mil) | 7.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SLS BIO Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SLS BIO Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
SLS BIO Co Ltd Frequently Asked Questions
What is SLS BIO Co Ltd(XKRX:246250)'s stock price today?
When is next earnings date of SLS BIO Co Ltd(XKRX:246250)?
Does SLS BIO Co Ltd(XKRX:246250) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |